Four Ways Health Execs Can Engage Providers
While it is difficult work, provider engagement is attainable. Here are some strategies that health systems can use to successfully engage their physicians.
Read More
The Forces Driving Specialty Drug Spending
What health execs need to know about the drugs and policies affecting spending.
Five Ways Diabetes Treatments are Changing
The disease management and insurer initiatives changing the diabetes landscape.
Lack of insulin competition high priority for FDA
FDA fast-tracks biosimiliar insulin products to elevate competition.
The Fight to End Misleading Info on Biosimilars
Industry groups are calling for clear FDA guidance on language used by biologic originators to protect market share.
The Promise of Specialty Drugs
What the future of specialty drugs holds for healthcare.
The Promises and Challenges of Gene Therapy
Gene therapy offers great hope for patients, but comes with a bevy of challenges for patients and payers alike.
New oral drugs treat MS
FDA approved 2 new multiple sclerosis drugs. Here's what you should know about them.
Are Drug Rebates Going Away?
A new HHS proposal could do away with-or at least forever change-PBM drug rebates. Here’s what that could mean for health execs.
OTC Meds Save Billions
How over-the-counter meds keep patients healthier.
Top Barriers to Population Health
A new study has revealing findings about the progress on population health objectives.
Most Hospitals Miss Out on Millions in Supply Chain Management Savings
The mistakes hospitals are making-and what they can do.
Why Some Groups Want to Kill Medicare for All
While the Democratic House and Democratic presidential candidates tout Medicare for All, opposing forces are also at work.
How One Health Plan Is Successfully Addressing SDOH
The tools and processes one of the largest not-for-profit Medicare Advantage plans uses to help seniors.
New postpartum drug comes at a high price
Postpartum drug is a game changer, but can women afford it?
FDA announces 3 big drug recalls
Several companies are recalling products due to contamination from substances such as carcinogens and glass-here’s what you should know.
Patient Control Over Health Data: Experts React
The ONC and CMS medical information transparency rule for patients, providers, and insurers may be the biggest change in healthcare system operations since the ACA. Here’s what to expect.
How to Run a Brainstorming Meeting that Actually Works
Typical idea-creation meetings are dull and don’t actually result in actionable items. Here’s how you can change that.
4 Ways Health Plans and Communities Can Address SDOH
The answers lie in innovation, collaboration, and a national approach.
Phishing Remains Large Threat to Hospitals
The Benefits of a Team-Based Approach in Disease Management
How one primary care practice used a team-based approach to reduce readmission rates for COPD patients.
FDA approves generic valsartan to mitigate shortages
FDA clears subcutaneous injectable to treat breast cancer
How Tech Giants Should Be Involved in Healthcare
The next best moves for Amazon, Apple, and Google in the transformation of healthcare.
10 Ways Health Execs Can Improve Organizational Productivity
A successful organization is a productive one, but a lot can stand in your way. Here’s how to get around the barriers to create a more efficient working environment.
Opinion: Pharmacy and Medical Data: A Vital Resource in Fighting the Opioid Epidemic
Access to broad snapshot of the patient’s pharmacy and medical data can help spot and address drug misuse.
Breakthrough nasal spray for depression not without risks
Nasal spray offers promise for treatment-resistant depression, but proceed with caution.
16 Ways to Hire Better Employees
Experts share 16 tips for acquiring top talent for a first-class workforce.
2019 Medicare Advantage Premiums Decline
New report shows that some premiums and deductibles were lower for 2019-and that members are using new tools to help them save.
HHS names FDA acting chief as Gottlieb resignation sparks worries
How FDA Chief Gottlieb’s resignation could impact the pharma industry.
